Jonathan Lippy

1.5k total citations
25 papers, 505 citations indexed

About

Jonathan Lippy is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Jonathan Lippy has authored 25 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Computational Theory and Mathematics. Recurrent topics in Jonathan Lippy's work include Computational Drug Discovery Methods (5 papers), Protein Degradation and Inhibitors (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Jonathan Lippy is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Protein Degradation and Inhibitors (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Jonathan Lippy collaborates with scholars based in United States, Germany and Sweden. Jonathan Lippy's co-authors include George L. Trainor, Kevin Kish, Catherine R. Burton, H.A. Lewis, John E. Macor, Hong Xiao, Gene M. Dubowchik, David R. Langley, Carol Krause and Prasanna Sivaprakasam and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Jonathan Lippy

25 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Lippy United States 13 349 124 118 90 83 25 505
Matthew G. Bursavich United States 17 504 1.4× 379 3.1× 149 1.3× 122 1.4× 106 1.3× 29 904
Niru B. Soni United States 13 488 1.4× 189 1.5× 203 1.7× 65 0.7× 218 2.6× 17 788
Alexander Flohr Switzerland 11 397 1.1× 204 1.6× 206 1.7× 127 1.4× 95 1.1× 18 740
Laura L. Rokosz United States 14 379 1.1× 167 1.3× 43 0.4× 38 0.4× 227 2.7× 26 660
Mihiret T. Sisay Germany 9 214 0.6× 83 0.7× 118 1.0× 44 0.5× 53 0.6× 12 365
Mary Pat Beavers United States 17 408 1.2× 192 1.5× 52 0.4× 39 0.4× 63 0.8× 25 729
Hemantkumar Deokar United States 11 228 0.7× 148 1.2× 67 0.6× 47 0.5× 60 0.7× 20 380
Stéphane De Cesco Canada 11 316 0.9× 200 1.6× 150 1.3× 23 0.3× 82 1.0× 12 487
Vivek Modi United States 9 494 1.4× 74 0.6× 156 1.3× 40 0.4× 98 1.2× 12 643
Henrik Moebitz Switzerland 5 325 0.9× 105 0.8× 58 0.5× 25 0.3× 119 1.4× 8 441

Countries citing papers authored by Jonathan Lippy

Since Specialization
Citations

This map shows the geographic impact of Jonathan Lippy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lippy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lippy more than expected).

Fields of papers citing papers by Jonathan Lippy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Lippy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lippy. The network helps show where Jonathan Lippy may publish in the future.

Co-authorship network of co-authors of Jonathan Lippy

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Lippy. A scholar is included among the top collaborators of Jonathan Lippy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Lippy. Jonathan Lippy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaudhry, Charu, Andrew J. Tebben, John S. Tokarski, et al.. (2021). An innovative kinome platform to accelerate small-molecule inhibitor discovery and optimization from hits to leads. Drug Discovery Today. 26(5). 1115–1125. 4 indexed citations
2.
Chen, Jing, Alan Futran, Sha Li, et al.. (2020). Leveraging Automation toward Development of a High-Throughput Gene Expression Profiling Platform. SLAS DISCOVERY. 26(3). 410–419. 4 indexed citations
3.
Shou, Wilson Z., Samuel W. Gerritz, David Harden, et al.. (2020). Rapid Compound Integrity Assessment for High-Throughput Screening Hit Triaging. SLAS DISCOVERY. 26(2). 242–247. 3 indexed citations
4.
Vasta, James D., Gregory Locke, Mark A. Pattoli, et al.. (2019). A High-Throughput BRET Cellular Target Engagement Assay Links Biochemical to Cellular Activity for Bruton’s Tyrosine Kinase. SLAS DISCOVERY. 25(2). 176–185. 9 indexed citations
5.
Fan, Yi, Joseph G. Naglich, Jonathan Lippy, et al.. (2018). Miniaturized High-Throughput Multiparameter Flow Cytometry Assays Measuring In Vitro Human Dendritic Cell Maturation and T-Cell Activation in Mixed Lymphocyte Reactions. SLAS DISCOVERY. 23(7). 742–750. 6 indexed citations
6.
Liu, Qingjie, Douglas G. Batt, Charu Chaudhry, et al.. (2018). Conversion of carbazole carboxamide based reversible inhibitors of Bruton’s tyrosine kinase (BTK) into potent, selective irreversible inhibitors in the carbazole, tetrahydrocarbazole, and a new 2,3-dimethylindole series. Bioorganic & Medicinal Chemistry Letters. 28(18). 3080–3084. 12 indexed citations
7.
Chen, Jing, Han Li, Peter Chase, et al.. (2017). Leveraging the IncuCyte Technology for Higher-Throughput and Automated Chemotaxis Assays for Target Validation and Compound Characterization. SLAS DISCOVERY. 23(2). 122–131. 10 indexed citations
8.
Fereshteh, Mark, Xin Li, Sha Li, et al.. (2016). Development of a Human Whole Blood Screening Platform to Monitor JAK/STAT Signaling Using High-Throughput Flow Cytometry. SLAS DISCOVERY. 21(8). 866–874. 6 indexed citations
9.
Sivaprakasam, Prasanna, Xiaojun Han, Rita L. Civiello, et al.. (2015). Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core. Bioorganic & Medicinal Chemistry Letters. 25(9). 1856–1863. 100 indexed citations
10.
Liu, Qingjie, Douglas G. Batt, Jonathan Lippy, et al.. (2015). Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton’s tyrosine kinase (BTK) and Janus kinase 2 (JAK2). Bioorganic & Medicinal Chemistry Letters. 25(19). 4265–4269. 23 indexed citations
11.
Zimmermann, Kurt, Harold Mastalerz, Walter L. Johnson, et al.. (2015). 9H-Carbazole-1-carboxamides as potent and selective JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(14). 2809–2812. 10 indexed citations
12.
Zhang, Litao, et al.. (2012). Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004–2009. Drug Discovery Today. 17(13-14). 733–740. 7 indexed citations
13.
Perez, Heidi L., Patrizia Banfi, J. A. Bertrand, et al.. (2012). Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists. Bioorganic & Medicinal Chemistry Letters. 22(12). 3946–3950. 29 indexed citations
14.
Schroeder, Gretchen M., Donna Wei, Patrizia Banfi, et al.. (2012). Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists. Bioorganic & Medicinal Chemistry Letters. 22(12). 3951–3956. 18 indexed citations
15.
Pedicord, Donna L., Sujatha Nagulapalli, Suhong Pang, et al.. (2010). An electrophoretic mobility shift assay for the identification and kinetic analysis of acetyl transferase inhibitors. Analytical Biochemistry. 402(1). 65–68. 15 indexed citations
16.
Ye, Xiang‐Yang, Yixin Li, Dennis Farrelly, et al.. (2008). Design, synthesis, and structure–activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARα/γ agonists. Bioorganic & Medicinal Chemistry Letters. 18(12). 3545–3550. 6 indexed citations
17.
Kim, Soong‐Hoon, John S. Tokarski, Kenneth J. Leavitt, et al.. (2007). Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkA. Bioorganic & Medicinal Chemistry Letters. 18(2). 634–639. 19 indexed citations
18.
Seethala, Ramakrishna, Rajasree Golla, Zhengping Ma, et al.. (2007). A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARα/γ activator. Analytical Biochemistry. 363(2). 263–274. 13 indexed citations
19.
Feldman, Patricia, et al.. (2001). A Scintillation Proximity Assay for RNA Detection. Analytical Biochemistry. 289(2). 239–245. 14 indexed citations
20.
Angeles, Thelma S., Jonathan Lippy, & Shi Yang. (2000). Quantitative, High-Throughput Cell-Based Assays for Inhibitors of trkA Receptor. Analytical Biochemistry. 278(2). 93–98. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew G. Bursavich Breakdown of academic impact, for papers by Niru B. Soni Breakdown of academic impact, for papers by Alexander Flohr Breakdown of academic impact, for papers by Laura L. Rokosz Breakdown of academic impact, for papers by Mihiret T. Sisay Breakdown of academic impact, for papers by Mary Pat Beavers Breakdown of academic impact, for papers by Hemantkumar Deokar Breakdown of academic impact, for papers by Stéphane De Cesco Breakdown of academic impact, for papers by Vivek Modi Breakdown of academic impact, for papers by Henrik Moebitz
Rankless by CCL
2026